House Set to Vote Today on Proposed FY 2011 Cuts to Research
Funding; Researchers Need to Contact Congress Now to Protect NIHThe House of
Representatives is scheduled to vote today on a funding bill for the remainder
of the current fiscal year that includes a dangerous $1.6 billion (5 percent)
cut for the National Institutes of Health (NIH). It is
imperative that researchers contact Congress to inform Representatives about
the benefits of NIH-funded research and the threats posed by this cut. ASH encourages all members to visit the ASH Advocacy Center to send a letter to their Representative in support of NIH. Read more.
President Obama Submits FY 2012 Budget Proposal to Congress, Seeks
2.4 Percent Increase for NIH Over FY 2010As the Congress
debates funding for FY 2011, President Obama released his FY 2012 budget proposal, which contains approximately $32 billion in funding for NIH, an
increase of $740 million over final FY 2010 funding levels. NIH Director
Francis S. Collins’ presentation and related materials concerning the agency’s
FY 2012 budget are available online at the NIH website. Read more.
Rejects Health Reform Repeal Proposal; Republican Efforts Shift to Eliminating
Funding for Implementation and Repealing Individual Provisions of LawThe U.S. Senate has rejected an amendment offered by Senate Minority Leader Mitch McConnell (R-KY) that
would have repealed the entire reform law enacted last year. The defeated
amendment was identical to a bill passed last month by the House of Representatives and marks
the first Senate attempt to repeal the law in the new 112th
Congress. Read more.
Chemotherapy Shortages Continue;
ASH Works with U.S. Senate on LegislationIn response to the record-breaking shortage of generic
drugs for cancer and other serious ailments, Senators Amy Klobuchar (D-MN) and
Bob Casey (D-PA) introduced legislation that would provide the Food and Drug
Administration (FDA) with tools to help address and prevent future medication
shortages. The Preserving Access to Life-Saving Medications
Act (S 296) will
require prescription drug manufacturers to give early notification to the FDA
of any incident that would likely result in a drug shortage. Read more.
Bone Marrow Failure Disease Research and Treatment Act Introduced
in HouseOn February 10, 2011,
Representative Doris Matsui (D-CA) introduced the Bone Marrow Failure Disease
Research and Treatment Act of 2011 (HR 640). Read more.
ASH Publishes Updated ITP GuidelineThe ASH Updated Clinical Practice
Guideline on the Evaluation and Management of Immune Thrombocytopenia (ITP) has
been published in Blood First
ASH Submits Recommendations to NIH Imaging in Tissue Engineering
and Regenerative Medicine Workshop Request for InformationASH has submitted recommendations to the Multi-Agency Tissue Engineering Science
(MATES) Interagency Working Group on
scientific issues the Society believes should be explored during an upcoming
"Imaging in Tissue Engineering and Regenerative Medicine" workshop. The
recommendations, which were based on the Society’s Policy Statement on Regenerative Medicine and a report from a 2009 ASH-convened regenerative medicine workshop, focus on
the need to establish real-time multimodal imaging to track cells administered
in regenerative medicine clinical trials and the need to develop and integrate
preclinical molecular imaging platforms and labeling probes for specialized
animal models. Read more.
NIH Announces Lasker Clinical Research Scholars
Research ProgramNIH has announced the Lasker
Clinical Research Scholars Program. The
program, a partnership between the NIH intramural and extramural communities
and the Lasker Foundation, seeks to bridge the widening gap between
cutting-edge research and improved patient care, and to nurture the next
generation of clinical researchers. Those selected for the program will be able
to take advantage of a unique combination of NIH funding, combining a period of
independent research in the NIH Intramural Research Program for 5 to 7 years,
with the opportunity for additional years of independent financial support
either at the NIH or at an extramural research institution. Letters of intent
for the program are due March 4, 2011, and applications are due April 4, 2011. Read more.
Up-to-Date on All Issues Affecting Hematology by Following ASH on Twitter!Get the latest updates on
ASH activities and breaking news stories by following us at ASH_Hematology.
back to top
Tell Congress to stop further cuts to research funding
Support the mission of ASH and help move hematology forward